SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The importance of continued follow-up in cancer trials: results from the TEAMM myeloma trial assessing the benefit of 12 weeks levofloxacin prophylaxis on febrile episodes or deaths

Iqbal, G; Drayson, M; Bowcock, S; Planche, T; Dunn, J (2019) The importance of continued follow-up in cancer trials: results from the TEAMM myeloma trial assessing the benefit of 12 weeks levofloxacin prophylaxis on febrile episodes or deaths. In: 5th International Clinical Trials Methodology Conference (ICTMC 2019), TRIALS, October 6th-9th 2019, Brighton, UK.
SGUL Authors: Planche, Timothy David

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (893kB) | Preview
Item Type: Conference or Workshop Item (Paper)
Additional Information: © The Author(s). 2019Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, andreproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: 1102 Cardiovascular Medicine And Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology, General & Internal Medicine
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: TRIALS
ISSN: 1745-6215
Dates:
DateEvent
22 October 2019Published
Publisher License: Creative Commons: Attribution 4.0
Web of Science ID: WOS:000491426300232
URI: https://openaccess.sgul.ac.uk/id/eprint/111381

Actions (login required)

Edit Item Edit Item